Realta Life Sciences, Inc.

This study is testing a new drug called RLS-0071 to see if it is safe and can help newborns who have brain damage from a lack of oxygen during birth. The drug is given alongside standard cooling therapy. Researchers will follow the babies for two years to check for safety and see…

This study is testing a new drug called RLS-0071 for patients who develop a severe immune reaction (graft-versus-host disease) after a stem cell transplant and do not get better with standard steroid treatment. Researchers will give different doses to hospitalized patients to see…